Company Monitoring Page for Takeda

latest headlines for company on cafepharma

With the $62B Shire buyout on track, Takeda plans to debut the newly merged company at JPMorgan
Endpoints
Mon, 11/12/18 - 11:39 am
Tags:
Takeda, Shire, M&A, Christophe Weber
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Channel News Asia
Sat, 11/10/18 - 12:40 pm
Tags:
Takeda, Shire, M&A, Europe
Takeda CEO confident about Shire merger
Pharmaforum
Thu, 11/8/18 - 09:44 am
Tags:
Takeda, Shire, M&A, shareholders, Pharma CEOs, Christophe Weber
Positive quarter from Takeda, waiting for completion of Shire deal
GoinPharma
Fri, 11/2/18 - 10:00 am
Tags:
Takeda, Shire, M&A, earnings
Takeda considering sale of OTC business in Europe ($11bn)
Bloomberg
Mon, 10/29/18 - 11:33 pm
Tags:
Takeda, Shire, M&A, OTC
Takeda is ready to auction off a PhIII favorite at Shire to clear the last hurdles to a $62B buyout
Enpoints
Sun, 10/28/18 - 07:47 pm
Tags:
Takeda, Shire, inflammatory bowel disease, IBD, ulcerative colitis, Crohn's Disease, M&A, SHP647
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
Tags:
BrainStorm Cell Therapeutics, Allergan, Pfizer, Clovis Oncology, Acorda Therapeutics, Takeda, Agios Pharmaceuticals, Shire, Teva Pharmaceutical, AbbVie
Microbiome Biotech Enterome and Takeda sign Crohn's Deal Worth Up To $600 Million+
CP Wire
Thu, 10/25/18 - 11:27 pm
Tags:
Enterome, Takeda, Crohn's Disease, EB8018
Thu, 10/25/18 - 12:41 pm
Tags:
Enterome, Takeda, Crohn's Disease, EB8018
Panel backing for key Shire drug beefs up Takeda's case for its $62B buyout
Fierce Pharma
Fri, 10/19/18 - 11:46 am
Tags:
Shire, FDA, Takeda, M&A
Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer
CP Wire
Fri, 10/19/18 - 09:19 am
Tags:
Takeda, Alunbrig, Xalkori, non-small cell lung cancer
Fri, 10/19/18 - 09:05 am
Tags:
Takeda, Alunbrig, Xalkori, non-small cell lung cancer
Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma
BioSpace
Mon, 10/8/18 - 11:36 pm
Tags:
Seattle Genetics, Takeda, Adcetris, peripheral T-cell lymphoma
Disgruntled Takeda alums demand a window into $62B Shire buy
Fierce Pharma
Thu, 10/4/18 - 12:07 pm
Tags:
Takeda, Shire, M&A
Seattle Genetics' and Takeda's Adcetris Meets Primary and Secondary Endpoints in Ph III Trial for T-Cell Lymphoma
CP Wire
Mon, 10/1/18 - 09:40 am
Tags:
Seattle Genetics, Takeda, Adcetris, T-cell lymphoma
Mon, 10/1/18 - 09:28 am
Tags:
Seattle Genetics, Takeda, Adcetris, T-cell lymphoma
Takeda Presents Superior Results for Alunbrig in ALK+ Non-Small Cell Lung Cancer
CP Wire
Tue, 09/25/18 - 09:42 am
Tags:
Takeda, Alunbrig, non-small cell lung cancer
Tue, 09/25/18 - 09:33 am
Tags:
Takeda, Alunbrig, non-small cell lung cancer
Takeda blesses a little biotech’s engineered toxin tech for multiple myeloma, triggering a bases loaded home run
Endpoints
Wed, 09/19/18 - 11:20 pm
Tags:
Molecular Templates, Takeda, Multiple Myeloma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Wed, 09/19/18 - 11:27 am
Tags:
Exelixis, Cabometyx, Takeda, Canada, Japan, Ipsen, renal cell carcinoma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.